Beyond Air, Inc. Increase (Decrease) in Accounts Receivable
Beyond Air, Inc. (XAIR) reported Increase (Decrease) in Accounts Receivable of $145.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- Beyond Air, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $145.00K, a 54.26% increase year-over-year.
- Beyond Air, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $26.00K, a 62.86% decline year-over-year.
- Beyond Air, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $260.00K, a 213.25% increase year-over-year.
- Beyond Air, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $88.00K, a 8.64% increase year-over-year.
- Beyond Air, Inc. increase (decrease) in accounts receivable for fiscal 2026 was $468.00K, a 20.00% increase from fiscal 2025.
- Beyond Air, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $390.00K, a 22.26% increase from fiscal 2024.
- Beyond Air, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $319.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $145.00K 10-Q · filed 2026-08-13 | $171.00K derived: sum of 2 quarters · filed 2026-08-13 | $431.00K derived: sum of 3 quarters · filed 2026-08-13 | $519.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $286.00K derived: sum of 2 quarters · filed 2026-06-26 | $374.00K derived: sum of 3 quarters · filed 2026-06-26 | $468.00K 10-K · filed 2026-06-26 |
| 2025-12-31 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | $348.00K derived: sum of 2 quarters · filed 2026-02-13 | $442.00K 10-Q · filed 2026-02-13 | $512.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $182.00K 10-Q · filed 2025-11-10 | $252.00K derived: sum of 3 quarters · filed 2026-08-13 | $335.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $94.00K 10-Q · filed 2026-08-13 | $164.00K derived: sum of 2 quarters · filed 2026-08-13 | $247.00K derived: sum of 3 quarters · filed 2026-08-13 | $328.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $153.00K derived: sum of 2 quarters · filed 2026-06-26 | $234.00K derived: sum of 3 quarters · filed 2026-06-26 | $390.00K 10-K · filed 2026-06-26 |
| 2024-12-31 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | $164.00K derived: sum of 2 quarters · filed 2026-02-13 | $320.00K 10-Q · filed 2026-02-13 | $345.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $237.00K 10-Q · filed 2025-11-10 | $262.00K derived: sum of 3 quarters · filed 2025-11-10 | $351.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $156.00K 10-Q · filed 2025-08-12 | $181.00K derived: sum of 2 quarters · filed 2025-08-12 | $270.00K derived: sum of 3 quarters · filed 2025-08-12 | $431.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $114.00K derived: sum of 2 quarters · filed 2025-06-20 | $275.00K derived: sum of 3 quarters · filed 2025-06-20 | $319.00K 10-K · filed 2025-06-20 |
| 2023-12-31 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | $250.00K derived: sum of 2 quarters · filed 2025-02-10 | $294.00K 10-Q · filed 2025-02-10 | |
| 2023-09-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | $205.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $44.00K 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |